Corsair Capital Management, L.P. Magenta Therapeutics, Inc. Transaction History

Corsair Capital Management, L.P.

  • $404 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.62 - $0.79 $41,635 - $53,051
67,154 Added 204.45%
100,000 $76,000
Q1 2023

May 12, 2023
BUY
$0.41 - $0.86 $13,466 - $28,247
32,846 New
32,846 $25,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Corsair Capital Management, L.P. Portfolio

Follow Corsair Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corsair Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Corsair Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email